Skip to main content
SpringerLink
Log in

PMDA issues revision of precautions for levonorgestrel

  • Unknown
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Pharmaceuticals and Medical Devices Agency of Japan. Revision of Precautions - Levonorgestrel (preparations indicated for emergency contraception). Internet Document : 9 Feb 2022. Available from: URL: https://www.pmda.go.jp/files/000244783.pdf

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

PMDA issues revision of precautions for levonorgestrel. Reactions Weekly 1893, 4 (2022). https://doi.org/10.1007/s40278-022-09787-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-09787-7

Search

Navigation